Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database

被引:28
作者
Wei, Shenhai [1 ]
Tian, Jintao [1 ]
Song, Xiaoping [1 ]
Wu, Bingqun [1 ]
Liu, Limin [2 ]
机构
[1] Tsinghua Univ, Dept Thorac Surg, Hosp 1, Beijing 100016, Peoples R China
[2] Capital Med Univ, Dept Physiol, Beijing 100069, Peoples R China
关键词
Non-small cell lung cancer; Cause of death; Overall survival; Lung cancer-specific survival; PRIMARY MALIGNANCIES; SURVIVAL; STAGE; LOBECTOMY; TIME; PNEUMONECTOMY; COMORBIDITY; DIAGNOSIS; PROGNOSIS; RESECTION;
D O I
10.1007/s00432-017-2522-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the probability of death (POD) from any causes by time after diagnosis of non-small cell lung cancer (NSCLC) and the factors associated with survival for NSCLC patients. A total of 202,914 patients with NSCLC from 2004 to 2013 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The overall survival (OS) and lung cancer-specific survival (LCSS) were calculated and POD from any causes at different time periods after diagnosis was explored. The predictive factors for OS, LCSS and survival from non-lung cancer deaths were investigated using multivariate analysis with Cox proportional hazards regression and competing risk regression analysis. The 5- and 10-year OS were 20.4% and 11.5%, accordingly that for LCSS were 25.5% and 18.4%, respectively. Lung cancer contributed 88.3% (n = 128,402) of the deaths. The POD from lung cancer decreased with time after diagnosis. In multivariate analysis, advanced age and advanced stage of NSCLC were associated with decreased OS and LCSS. Comparing to no surgery, any kind of resection conferred lower risk of death from lung cancer and higher risk of dying from non-lung cancer conditions except lobectomy or bilobectomy, which was associated with lower risk of death from both lung cancer and non-lung cancer conditions. Most of the patients with NSCLC died from lung cancer. Rational surveillance and treatment policies should be made for them. Early stage and lobectomy or bilobectomy were associated with improved OS and LCSS. It is reasonable to focus on early detection and optimal surgical treatment for NSCLC.
引用
收藏
页码:145 / 155
页数:11
相关论文
共 33 条
  • [11] Primary lung cancer and extrapulmonary malignancy
    Hofmann, Hans-Stefan
    Neef, Heinz
    Schmidt, Peter
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (04) : 653 - 658
  • [12] RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER
    HOLMES, CE
    RUCKDESCHEL, JC
    JOHNSTON, M
    THOMAS, PA
    DESLAURIERS, J
    GROVER, FL
    HILL, LD
    FELD, R
    GINSBERG, RJ
    MOUNTAIN, CF
    DZUIBAN, S
    KIELY, M
    MCKNEALLY, MF
    MOORES, DWO
    RAMNES, C
    WAGNER, H
    BUNN, P
    CHU, H
    DIENHART, D
    HAZUKA, M
    KINZIE, J
    SORENSEN, J
    VANCE, V
    BRAUN, T
    HOPEMAN, A
    KANE, M
    RUSS, P
    WHITMAN, GJR
    FALL, SM
    HANSEN, DP
    HENDERSON, RH
    MONCRIEF, CL
    PAULING, F
    SIMS, J
    TELL, D
    WISELYCARR, S
    ABERNATHY, CM
    CLARK, DA
    MCCROSKEY, B
    MOORE, G
    MOORE, F
    MYERS, A
    WHITE, M
    BROOKS, RJ
    BULL, M
    JOHNSON, FB
    NEIMYR, M
    PAQUETTE, FR
    SACCOMANNO, G
    LAD, T
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (03) : 615 - 622
  • [13] Howlader N., 1975, SEER CANC STAT REV 1
  • [14] Five-year survival does not equal cure in non-small cell lung cancer: A Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10-to 18-year survival
    Hubbard, Matthew O.
    Fu, Pingfu
    Margevicius, Seunghee
    Dowlati, Afshin
    Linden, Philip A.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 143 (06) : 1307 - 1313
  • [15] Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis
    Janssen-Heijnen, M. L. G.
    van Erning, F. N.
    De Ruysscher, D. K.
    Coebergh, J. W. W.
    Groen, H. J. M.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (05) : 902 - 907
  • [16] Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer
    Janssen-Heijnen, MLG
    Smulders, S
    Lemmens, VEPP
    Smeenk, FWJM
    van Geffen, HJAA
    Coebergh, JWW
    [J]. THORAX, 2004, 59 (07) : 602 - 607
  • [17] Jemal Ahmedin., 2009, CA Cancer J Clin, V59, P1, DOI [10.1002/caac.20073.Available, DOI 10.1002/CAAC.20073.AVAILABLE]
  • [18] Second lung cancers in patients after treatment for an initial lung cancer
    Johnson, BE
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18): : 1335 - 1345
  • [19] Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality
    Jorgensen, T. L.
    Hallas, J.
    Friis, S.
    Herrstedt, J.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (07) : 1353 - 1360
  • [20] Cause of Death in Older Men After the Diagnosis of Prostate Cancer
    Ketchandji, Melanie
    Kuo, Yong-Fang
    Shahinian, Vahakn B.
    Goodwin, James S.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (01) : 24 - 30